Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)

Geffen Kleinstern; Daniel R O'Brien; Brian Kabat; Kari G Rabe; Aaron D Norman; Huihuang Yan; Celine M Vachon; Shulan Tian; Timothy G Call; Sameer A Parikh

doi:10.1182/blood-2019-124346

Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)

Geffen Kleinstern, Daniel R O'Brien, Brian Kabat, Kari G Rabe, Aaron D Norman, Huihuang Yan, Celine M Vachon, Shulan Tian, Timothy G Call, Sameer A Parikh

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	American English
Pages (from-to)	852
Number of pages	1
Journal	Blood
Volume	134
Issue number	supp 1
DOIs	https://doi.org/10.1182/blood-2019-124346
State	Published - 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood-2019-124346

Cite this

Kleinstern, G., O'Brien, D. R., Kabat, B., Rabe, K. G., Norman, A. D., Yan, H., Vachon, C. M., Tian, S., Call, T. G., & Parikh, S. A. (2019). Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL). Blood, 134(supp 1), 852. https://doi.org/10.1182/blood-2019-124346

@article{468f62ef92f646a7a0f20bd12c3dc351,

title = "Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)",

author = "Geffen Kleinstern and O'Brien, {Daniel R} and Brian Kabat and Rabe, {Kari G} and Norman, {Aaron D} and Huihuang Yan and Vachon, {Celine M} and Shulan Tian and Call, {Timothy G} and Parikh, {Sameer A}",

year = "2019",

doi = "10.1182/blood-2019-124346",

language = "American English",

volume = "134",

pages = "852",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "supp 1",

}

Kleinstern, G, O'Brien, DR, Kabat, B, Rabe, KG, Norman, AD, Yan, H, Vachon, CM, Tian, S, Call, TG & Parikh, SA 2019, 'Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)', Blood, vol. 134, no. supp 1, pp. 852. https://doi.org/10.1182/blood-2019-124346

TY - JOUR

T1 - Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)

AU - Kleinstern, Geffen

AU - O'Brien, Daniel R

AU - Kabat, Brian

AU - Rabe, Kari G

AU - Norman, Aaron D

AU - Yan, Huihuang

AU - Vachon, Celine M

AU - Tian, Shulan

AU - Call, Timothy G

AU - Parikh, Sameer A

PY - 2019

Y1 - 2019

U2 - 10.1182/blood-2019-124346

DO - 10.1182/blood-2019-124346

M3 - Meeting Abstract

SN - 0006-4971

VL - 134

SP - 852

JO - Blood

JF - Blood

IS - supp 1

ER -